LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the appointments of Elizabeth Yeu, M.D., Partn…
Author: Business Wire
Zenni Solves COVID-19 Mask Frustration with New Anti-Fog Glasses Lenses
NOVATO, Calif.–(BUSINESS WIRE)–Zenni, the nation’s largest online eyewear retailer, today announced a two-in-one anti-fog + anti-reflective lens solution to solve a significant pain point for glasses wearers during the pandemic. Developed in 2020 as …
Leo Lens Pharma Announces A Corporate Name Change to MediPrint™ Ophthalmics
SAN DIEGO–(BUSINESS WIRE)–Leo Lens Pharma Announces A Corporate Name Change to MediPrint™ Ophthalmics
My Eyelab Celebrates Successful 2020, Ranked in Entrepreneur’s Franchise 500
PALM SPRINGS, Fla.–(BUSINESS WIRE)–My Eyelab, a retail brand of Now Optics, is staying true to its vision of modernizing the eye care experience for all people and making franchising easy. My Eyelab saw tremendous growth this past year opening 28 new…
Eyenovia to Present at the Ophthalmology Innovation Summit (OIS) Presbyopia Innovation Showcase
NEW YORK–(BUSINESS WIRE)– #Eyenovia–Eyenovia consultant Dr. David Wirta will speak at the Ophthalmology Innovation Summit Presbyopia Innovation Showcase on January 28.
Credence MedSystems Receives a Strategic Investment From One of the World’s Leading Pharmaceutical Companies
MENLO PARK, Calif.–(BUSINESS WIRE)–Credence MedSystems announced today that Novartis has made a strategic investment in the Company. The investment will advance ongoing development and scaling of Credence’s innovative drug delivery systems, with an i…
Samenvatting: Credence MedSystems ontvangt een strategische investering van een van 's werelds toonaangevende farmaceutische bedrijven
MENLO PARK, Californië–(BUSINESS WIRE)–Credence MedSystems heeft vandaag aangekondigd dat Novartis een strategische investering in het bedrijf heeft gedaan. De investering zal de voortdurende ontwikkeling en opschaling van de innovatieve medicijnafgi…
Credence MedSystems erhält eine strategische Investition von einem der weltweit führenden Pharmaunternehmen
MENLO PARK, Kalifornien–(BUSINESS WIRE)–Credence MedSystems gab heute bekannt, dass Novartis eine strategische Investition in das Unternehmen getätigt hat. Die Investition wird die Weiterentwicklung und Skalierung der innovativen Arzneimittelabgabesy…
Resumen: Credence MedSystems recibe una inversión estratégica de una de las principales compañías farmacéuticas del mundo
MENLO PARK, California–(BUSINESS WIRE)–Credence MedSystems ha anunciado hoy que Novartis ha realizado una inversión estratégica en la compañía. Dicha inversión favorecerá el desarrollo en curso y la ampliación de los innovadores sistemas de suministr…
Riassunto: Credence MedSystems ottiene un investimento strategico da una delle case farmaceutiche più prestigiose al mondo
MENLO PARK, California–(BUSINESS WIRE)–Credence MedSystems ha annunciato in data odierna che Novartis ha effettuato un investimento strategico nella società. L’investimento favorirà lo sviluppo già in corso e la scalabilità degli innovativi sistemi d…
Credence MedSystems reçoit un investissement stratégique de la part de l’une des plus grandes compagnies pharmaceutiques au monde
MENLO PARK, Californie–(BUSINESS WIRE)–Credence MedSystems a annoncé aujourd’hui que Novartis avait réalisé un investissement stratégique dans sa Société. Cet investissement permettra de faire progresser le développement et l’extension en cours, des …
Genentech’s Faricimab Meets Primary Endpoint in Two Global Phase III Studies and Shows Potential to Extend Time Between Treatments up to 16 Weeks for People With Neovascular Age-Related Macular Degeneration
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global Phase III studies, TENAYA and LUCERNE, evaluating its invest…
Global Dry Eye Syndrome Drugs Market Research 2021-2025 | Industry Impact Analysis | Technavio
LONDON–(BUSINESS WIRE)– #GlobalDryEyeSyndromeDrugsMarket–The Dry Eye Syndrome Drugs Market will grow by $ 2.08 bn during 2021-2025
Eyedaptic Augmented Reality Visual Aid Granted Patent to Further Aid Those With Macular Degeneration and Low Vision
LAGUNA HILLS, Calif.–(BUSINESS WIRE)– #AI–Eyedaptic announces Patent Grant and Equity Crowdfunding
Lineage Posts Series of Webinars Highlighting Recent Progress With its Three Clinical-Stage Allogeneic Cell Transplant Programs
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies to address unmet medical needs, recently highlighted to member…
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with …
Ocular Therapeutix™ Presents Interim Topline Data from the Phase 1 Clinical Trial of OTX-TIC in Patients with Primary Open Angle Glaucoma or Ocular Hypertension at the 10th Annual Glaucoma 360 New Horizons Forum
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S.
GENEVA–(BUSINESS WIRE)–Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S.
Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S.
GENEVA–(BUSINESS WIRE)–Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S.
Korea’s KAHF-Designated Hospitals Taking the Lead in Protecting Rights and Interest of International Patients and Offering Quality Medical Services
SEOUL, South Korea–(BUSINESS WIRE)– #CHAFertilityCenter–KAHF-designated hospitals of Korea protect rights for international patients and offer excellent medical services.